WS2: Evaluating Imaging Biomarkers for Schizophrenia: Issues in Identification, Categorization and Evaluation

Chairs: Nathan Chen, MD, PhD; Susan DeSanti, PhD; Steven Potkin, MD; Henry Riordan, PhD

Identifying relevant biomarkers for schizophrenia is increasingly important for drug development and use in personalized medicine.  This workshop will focus on identifying and evaluating imaging biomarkers in schizophrenia.  It will include those related to anatomical, functional, and circuitry measures and will seek to describe their value, their limitations and gaps in our understanding about them that must be filled to optimize their value.  At this workshop, data from a review of current literature will be presented for evaluation and discussion with the objective of developing a white paper or manuscript for publication.